Not Yet RecruitingNot Applicable

Effect of Mojzisova Method on Pain, Menstrual Symptom and Insomnia in PD

Pakistan26 participantsStarted 2024-06

Plain-language summary

This project was a Randomized controlled trial conducted to check the effectiveness of mojzisova method in primary dysmenorrhea for pain, menstrual symptoms and insomnia. Duration was of 6 months, convenient sampling was done, subject following eligibility criteria from DHQ hospital Toba Tek were randomly assigned, baseline assessment was done, Group A paarticipants were given baseline treatment along with mojzisova method, Group B participants were given baseline treatment along with stretching exercises, post intervention assessment was done, via WALIDD, Numeric pain rating scale (NPRS) and Pittsburgh sleep quality index (PSQI) questionnaire 45 minutes per session, 2 sessions per month for 3 months, data was analyzed by using SPSS version 26.

Who can participate

Age range15 Years – 30 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Pain must be recurrent (at least following three menstrual cycles). * No history of any blood problems, such as thalassemia, folate insufficiency, or anemia due to a lack of iron. Five criteria to fulfill to be considered primary dysmenorrhea. * Hypogastrium pain during menstruation. * Irradiation of pain to lower back, lower limbs or lingual region. * Inability to perform daily activity. * The need for medical management or self-medication to control pain Nulliparous women with primary dysmenorrhea. Exclusion Criteria: * Female with history of any specific disease. * Female with endocrine disorders. * Had gone major surgery. * Diagnosis of secondary dysmenorrhea. * Having symptoms such as numbness and tingling sensation.

What they're measuring

WALIDD

Timeframe: 4th week

NPRS

Timeframe: 4th week

PSQI Questionnaire

Timeframe: 4th week

Trial details

NCT IDNCT06460870

SponsorRiphah International University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-09

Contact for this trial

Imran Amjad, Phd

03324390125 imran.amjad@riphah.edu.pk

View on ClinicalTrials.gov More Primary Dysmenorrhea trials

Plain-language summary

Who can participate

Age range15 Years – 30 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.